OT: Breaking News on Food Processing & Packaging - Europe

[Guest guest]

Breaking News on Food Processing & Packaging - Europe

Previous page : EFSA issues guidance on lupin allergies

Print

EFSA issues guidance on lupin allergies

16/01/2006- The growing popularity of lupin in Europe has increased concerns

that some consumers could be unwittingly exposed to allergic reactions.

Lupin, a legume, has an average protein content of just over 30 per cent,

compared with 44 to 48 per cent in soybeans.

The ingredient has increasingly been recognised for its nutritional and food

processing qualities, and consumption has become much more widespread since

the introduction of lupin flour as an ingredient in wheat flour in the

1990s.

It is also increasingly being used in food formulations to replace soy flour

in speciality bakery and pasta products.

But allergic reactions to lupin have also been well documented. The European

Food Safety Authority (EFSA) says that IgE-binding proteins of lupin flour

extracts have been identified and show in vitro cross-reactivities with

peanut and other legumes, although the most clinically relevant

cross-reactions are with peanut proteins.

This means that lupin flour could pose a risk to consumers with food

allergies, notable peanuts. Researchers in the UK have cautioned that people

with peanut allergy - about 1 per cent of the UK population - should avoid

any products containing it until they have another allergy test.

A team at the Royal Free Hospital, London, who published their findings in a

recent edition of The Lancet, (2005; 365: 1360), highlighted the case of a

25-year-old woman who, in August 2004, had an allergic reaction after eating

a restaurant meal of chicken, French-fried potato, and onion rings.

Anaphylaxis - a life-threatening allergic reaction - was diagnosed.

According to the UK researchers, the consumer knew she had a severe allergy

to peanuts, but not to lupin, later identified in the onion ring batter she

had consumed.

EFSA says there is no definite indication that technological treatments

alter the allergenic potential of lupin, although reduction in allergenicity

has been reported after autoclaving lupin seeds at 138°C for 30 minutes. The

frequency of allergic reactions to lupin in the general population is

unknown.

The authority says that most, though not all, allergic reactions have been

reported in peanut allergic individuals. The possibility of under-reporting

of allergy cases cannot be excluded, as until recently lupin was a hidden

ingredient in various bakery and meat products.

One controlled study in peanut allergic patients suggests a clinically

relevant cross-reactivity rate of about 30 per cent, but higher (68 per

cent) rates have been reported. Clinical reactions range from mild local

reactions to systemic anaphylaxis.

Ingested doses of lupin flour reported to have triggered clinical reactions

range from 265 to 1000 mg, but the lowest dose triggering reactions has not

been established.

Copyright - Unless otherwise stated all contents of this web site are ©

2000/2006 ­ Decision News Media SAS ­ . For permission to

reproduce any contents of this web site, please email our Syndication

department: contact our Syndication department. Full details for the use of

materials on this site can be found in the Terms & Conditions.

contact the editor

Print